Literature DB >> 25028349

GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study.

Kenneth B Margulies1, Kevin J Anstrom2, Adrian F Hernandez2, Margaret M Redfield2, Monica R Shah2, Eugene Braunwald2, Thomas P Cappola1.   

Abstract

Entities:  

Keywords:  clinical trial; glucagon-like peptide-1; heart failure; insulin resistance

Mesh：

Substances：

Year:  2014        PMID： 25028349      PMCID： PMC4102890          DOI： 10.1161/CIRCHEARTFAILURE.114.000346

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  48 in total

1.  Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

Authors:  Roberto Latini; Serge Masson; Inder Anand; Dianne Judd; Aldo P Maggioni; Yann-Tong Chiang; Maurizio Bevilacqua; Monica Salio; Paola Cardano; Peter H J M Dunselman; Nicolaas J Holwerda; Gianni Tognoni; Jay N Cohn
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

Review 2.  Glucagon-like peptide-1.

Authors:  M E Doyle; J M Egan
Journal:  Recent Prog Horm Res       Date:  2001

3.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors:  Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

Review 4.  Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function.

Authors:  R Perfetti; P Merkel
Journal:  Eur J Endocrinol       Date:  2000-12       Impact factor: 6.664

5.  Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.

Authors:  Friedrich M Fruhwald; Astrid Fahrleitner-Pammer; Rudolf Berger; Francisco Leyva; Nick Freemantle; Erland Erdmann; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi; Jean-Claude Daubert; John G F Cleland
Journal:  Eur Heart J       Date:  2007-02-13       Impact factor: 29.983

6.  Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

Authors:  Josephine M Egan; Graydon S Meneilly; Joel F Habener; Dariush Elahi
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

7.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

Authors:  Alexandre Mebazaa; Markku S Nieminen; Milton Packer; Alain Cohen-Solal; Franz X Kleber; Stuart J Pocock; Roopal Thakkar; Robert J Padley; Pentti Põder; Matti Kivikko
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

8.  Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.

Authors:  Juan Carlos Osorio; William C Stanley; Axel Linke; Michele Castellari; Quy N Diep; Ashish R Panchal; Thomas H Hintze; Gary D Lopaschuk; Fabio A Recchia
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

Review 9.  Statistical models and patient predictors of readmission for heart failure: a systematic review.

Authors:  Joseph S Ross; Gregory K Mulvey; Brett Stauffer; Vishnu Patlolla; Susannah M Bernheim; Patricia S Keenan; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2008-07-14

10.  Epidemiology and practice patterns of acute decompensated heart failure.

Authors:  Mark A Munger; Orly Carter
Journal:  Am J Health Syst Pharm       Date:  2003-08-15       Impact factor: 2.637
View more
  14 in total

1.  Multiphasic Regulation of Systemic and Peripheral Organ Metabolic Responses to Cardiac Hypertrophy.

Authors:  Chong Wee Liew; Shanshan Xu; Xuerong Wang; Maximilian McCann; Hyerim Whang Kong; Andrew C Carley; Jingbo Pang; Giamila Fantuzzi; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

Review 2.  Turning Failure into Success: Trials of the Heart Failure Clinical Research Network.

Authors:  Emer Joyce; Michael M Givertz
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

3.  Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.

Authors:  Kenneth B Margulies; Adrian F Hernandez; Margaret M Redfield; Michael M Givertz; Guilherme H Oliveira; Robert Cole; Douglas L Mann; David J Whellan; Michael S Kiernan; G Michael Felker; Steven E McNulty; Kevin J Anstrom; Monica R Shah; Eugene Braunwald; Thomas P Cappola
Journal:  JAMA       Date:  2016-08-02       Impact factor: 56.272

4.  Mitochondrial dysfunction and its impact on diabetic heart.

Authors:  Suresh Kumar Verma; Venkata Naga Srikanth Garikipati; Raj Kishore
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-09-01       Impact factor: 5.187

Review 5.  Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit.

Authors:  Ersilia M DeFilippis; Michael M Givertz
Journal:  Curr Heart Fail Rep       Date:  2016-06

6.  Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study.

Authors:  Carlo B Giorda; Roberta Picariello; Barbara Tartaglino; Lisa Marafetti; Fabiana Di Noi; Annalisa Alessiato; Giuseppe Costa; Roberto Gnavi
Journal:  BMJ Open       Date:  2015-06-05       Impact factor: 2.692

Review 7.  Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.

Authors:  Aude Angelini; Xinchun Pi; Liang Xie
Journal:  Front Physiol       Date:  2017-12-12       Impact factor: 4.566

Review 8.  Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.

Authors:  Martin Lorenz; Francesca Lawson; David Owens; Denis Raccah; Christine Roy-Duval; Anne Lehmann; Riccardo Perfetti; Lawrence Blonde
Journal:  Cardiovasc Diabetol       Date:  2017-01-13       Impact factor: 9.951

9.  Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis.

Authors:  Konstantinos Batzias; Alexios S Antonopoulos; Evangelos Oikonomou; Gerasimos Siasos; Evanthia Bletsa; Panagiota K Stampouloglou; Chara-Vasiliki Mistakidi; Marina Noutsou; Niki Katsiki; Periklis Karopoulos; Georgios Charalambous; Anastasia Thanopoulou; Nicholas Tentolouris; Dimitris Tousoulis
Journal:  J Diabetes Res       Date:  2018-12-04       Impact factor: 4.011

10.  Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial.

Authors:  Abhinav Sharma; Andrew P Ambrosy; Adam D DeVore; Kenneth B Margulies; Steven E McNulty; Robert J Mentz; Adrian F Hernandez; Gary Michael Felker; Lauren B Cooper; Anuradha Lala; Justin Vader; John D Groake; Barry A Borlaug; Eric J Velazquez
Journal:  ESC Heart Fail       Date:  2018-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.